Some traditional Chinese medicine concept stocks rose. As of press release, Modern Chinese Medicine Group (01643) rose 4.29% to HK$0.365; Zhongzhi Pharmaceutical (03737) rose 2.84% to HK$1.45; and Tong Ren Tang Technology (01666) rose 2.08% to HK$6.39.
The Zhitong Finance App learned that some traditional Chinese medicine concept stocks have risen. As of press release, Modern Chinese Medicine Group (01643) rose 4.29% to HK$0.365; Zhongzhi Pharmaceutical (03737) rose 2.84% to HK$1.45; Tong Ren Tang Technology (01666) rose 2.08% to HK$6.39; and Baiyun Mountain (00874) rose 1.65% to HK$21.5.
According to the news, Wang Zhiyong, deputy director of the State Administration of Traditional Chinese Medicine, recently stated at the 2023 China Pharmaceutical Industry Development Conference that the next step is to further strengthen policy supply, increase protection, maintain the safety of traditional Chinese medicine development, effectively transform the resource advantages of traditional Chinese medicine into industrial advantages and competitive advantages, and add glory to the high-quality development of the pharmaceutical industry through the iterative opening of the traditional Chinese medicine industry.
CITIC Construction Investment pointed out that in terms of traditional Chinese medicine, favorable policies continue to be released, and the decline in collection is in line with expectations. ① Brand Chinese medicine companies with strong brand extension, channel expansion, and pricing capabilities will gradually enter a stage of high-quality development. ② Policy dividends continue to be released, and prescription doses of traditional Chinese medicine can be expected. ③ The valuation is at a historically low level.